Evaxion Biotech (EVAX) announced: Evaxion has hired a new Chief Executive Officer, CEO, to accelerate the strategic development and execution of the vast business opportunities at hand after having matured the Company’s AI platforms over the past 15 years. Christian Kanstrup has accepted the role as CEO of Evaxion. Kanstrup has held several senior leadership positions at Novo Nordisk (NVO), including Head of Biopharma Operations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EVAX:
- Evaxion announces Executive Management Changes to strengthen the AI-strategy
- Evaxion Biotech reports Q2 EPS (21c), two estimates (21c)
- Evaxion Announces Business Update and Second Quarter 2023 Financial Results
- Evaxion Biotech announces financing commitments up to $20M
- Evaxion announces financing commitments totaling up to USD 20 million with Negma Group
